Connect your AI

Allogene Therapeutics ALLO Price / sales

Price / sales at other companies

Bristol-Myers SquibbBMY

2.6×-0.1×

Gilead SciencesGILD

5.8×+1.0×

PrecigenPGEN

102.3×—

CRISPR TherapeuticsCRSP

1,112.8×+1,035×

CytomX TherapeuticsCTMX

28.6×+28.2×

Janux TherapeuticsJANX

61.6×-109×

Other financials

Income statement

Revenue-—

Operating income-$46.1M+29.3%

Net income-$42.6M+28.7%

EPS (diluted)-$0.18+35.7%

Balance sheet

Cash & equivalents$40.6M-23.0%

Total debt$81.1M-8.9%

Total equity$278.9M-27.6%

Total assets$396.0M-22.1%

Cash flow

Operating cash flow-$12.9M+75.6%

CapEx$9.0K-90.9%

Free cash flow-$12.9M+75.6%

Valuation

Market cap$711.02M+164%

Enterprise value$751.47M+146%

Profitability

Operating margin-1,241,813.6%-2,018,140pp

Net margin-1,170,863.6%-2,007,890pp

FCF margin-913,609.1%-1,474,890pp

Returns & leverage

Return on equity-52.3%-5.7pp

Debt / equity0.3×+0.1×

Current ratio9.6×-0.1×

Where this comes from

Calculated from Allogene Therapeutics’s reported figures.

market cap/total revenue=20,300.1×

Based on the most recent quarter.

The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Allogene Therapeutics's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Allogene Therapeutics's price / sales?: Allogene Therapeutics (ALLO) reported price / sales of 20,300.1× in Q4 2024.
How has Allogene Therapeutics's price / sales changed year-over-year?: Allogene Therapeutics's price / sales increased by 257.0% year-over-year, from 5,686× to 20,300.1×.
What is the long-term trend for Allogene Therapeutics's price / sales?: Over 3 years (2021 to 2024), Allogene Therapeutics's price / sales has grown at a 928.9% compound annual growth rate (CAGR), from 18.6× to 20,300.1×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.